France· FR:69614207
NORPROLAC 150 microgrammes, comprimé
A quinagolide product containing chlorhydrate de quinagolide, registered in France by FERRING (FRANCE), on the national reimbursement list. The same ATC class is registered in 9 of our 19 countries.
Checked against Base de données publique des médicaments — BDPM (France) on
Informational only — not a medical device.
Where it is registered
Quinagolide is registered in 9 of 19 countries.
Countries holding a registration under ATC G02CB04 (quinagolide), each read from that country’s own register.
- This record: France, from Base de données publique des médicaments — BDPM (France)
- 6 of them publish a price we can compare per daily dose
Quinagolide · ATC G02CB04
9 / 19 countries
- Belgiumprice
- Czechiaprice
- Denmark
- Finlandprice
- Franceprice
- Germany
- Polandprice
- Switzerlandprice
- United Kingdom
The record
At a glance
Base de données publique des médicaments — BDPM (France)- Active substance
- CHLORHYDRATE DE QUINAGOLIDE
- Manufacturer
- FERRING (FRANCE)
- Country
- France (FR)
- ATC code
- G02CB04
- ATC class
- Quinagolide
- Defined daily dose
- 75 mcg, O
- Reimbursed
- Yes
- Source register
- Base de données publique des médicaments — BDPM (France)
- Last checked
- September 12, 2026
Packs & prices · 1
1 priced- cip133400933865146plaquette(s) thermoformée(s) aluminium de 30 comprimé(s)EUR 45.81
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Quinagolide in 9 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- United KingdomNorprolac 25microgram tabletsFerring Pharmaceuticals Ltd
- SwedenNorprolac 150 mikrogram TablettFerring Läkemedel AB
- SwitzerlandNorprolac 150 ug, TablettenFerring AG
- FinlandNorprolacFerring Lääkkeet Oy
- BelgiumNorprolac 150 µgFerring
- SpainNORPROLAC 25 MICROGRAMOS Y 50 MICROGRAMOS COMPRIMIDOSFerring S.A.
- PolandNorprolacFerring GmbH
- GermanyNorprolacFerring Gmbh
Authorised across Europe · EMA
The same active substance is authorised in 9 EEA countries. Names it is sold under:
- Austria · Norprolac
- Czechia · Norprolac
- Germany · Norprolac
- United Kingdom (Northern Ireland) · Norprolac, Quinagolide Aspire Pharma
- Greece · Norprolac
- Hungary · Norprolac
- Netherlands · Norprolac
- Poland · Norprolac
- Slovakia · Norprolac
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Base de données publique des médicaments — BDPM (France). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/f9f8879e-cf77-46df-bd89-376b0e636460 GET /v1/drugs/f9f8879e-cf77-46df-bd89-376b0e636460?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"cis": "69614207",
"date_amm": "1995-02-23",
"type_amm": "Procédure nationale",
"numero_ue": null,
"substance": "CHLORHYDRATE DE QUINAGOLIDE",
"atc_source": "fr_atc_restore_2026-09-06",
"statut_amm": "Autorisation active",
"statut_bdm": "Warning disponibilité",
"forme_pharmaceutique": "comprimé",
"voies_administration": "orale",
"etat_commercialisation": "Non commercialisée",
"surveillance_renforcee": "Non"
}See everything about quinagolide.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.